What changed in this filing

/stocks — the workspaceLOADING

Item 1. Financial Statements

2026-08-14 compared with 2026-05-14 · 423 added, 738 removed, 145 unchanged (89% of the section changed)

2 unchanged sentences

CONDENSED CONSOLIDATED BALANCE SHEETS

As of March 31, 2026 (Unaudited) and

As of June 30, 2026 (Unaudited) and

December 31, 2025

3 unchanged sentences

Prepaid expenses

Marketable securities held in Trust Account

Total current assets

14 unchanged sentences

shares authorized, 5,595,000

and 5,595,000 shares subject to possible redemption as of March 31, 2026 and December 31, 2025, respectively

and 5,595,000 shares subject to possible redemption as of June 30, 2026 and December 31, 2025, respectively

Shareholders’ Equity:

3 unchanged sentences

and 1,708,575

shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively

Additional paid-in capital

6 unchanged sentences

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND

COMPREHENSIVE INCOME (LOSS)

For the three months ended March 31, 2026 and 2025

COMPREHENSIVE INCOME

For the three and six months ended June 30,

2026 and 2025 (Unaudited)

Currency expressed in United States dollars (“US$”),

1 unchanged sentence

Three Months Ended

Six Months Ended

Formation and operating costs

Administrative fee

operating expenses

from operations

Other income:

Administrative

Total operating

Loss from operations

Other income/(loss):

Interest income

Income earned on marketable securities held

in Trust Account

Income (loss) before income

Income earned on marketable securities

held in Trust Account

Change in fair

value of over-allotment liability

Income before income taxes

Income taxes provision

income (loss)

Other comprehensive income

Other comprehensive

Comprehensive

income (loss)

Basic and diluted weighted

Basic weighted

average ordinary shares outstanding, redeemable ordinary shares

Basic and diluted earnings

Basic earnings

per ordinary share, redeemable ordinary shares

Basic and diluted weighted

Basic weighted

average ordinary shares outstanding, non-redeemable ordinary shares (1)

Basic and diluted loss

Basic loss per

ordinary share, non-redeemable ordinary shares

Diluted weighted

average ordinary shares outstanding, redeemable ordinary shares

Diluted earnings

per ordinary share, redeemable ordinary shares

Diluted weighted

average ordinary shares outstanding, non-redeemable ordinary shares (1)

per ordinary share, non-redeemable ordinary shares

The numbers for the six and three months ended June 30, 2025 exclude up to 38,750 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).

The accompanying notes are an

2 unchanged sentences

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)

the three months ended March 31, 2026 and 2025 (Unaudited)

the six months ended June 30, 2026 and 2025 (Unaudited)

expressed in United States dollars (“US$”), except for number of shares

the three months ended March 31, 2026

the three and six months ended June 30, 2026

Ordinary Shares

4 unchanged sentences

as of March 31, 2026 (Unaudited)

For the three months ended

March 31, 2025

of ordinary share subject to redemption value

Balance as of June 30, 2026 (Unaudited)

For the three and

six months ended June 30, 2025

Ordinary Shares

Shareholders’

Shareholder’s

of January 1, 2025

as of March 31, 2025 (Unaudited)

The number include up to 187,500 and 187,500 ordinary shares

subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters as of January 1, 2025 and March

31, 2025 (see Note 5).

Proceeds allocated to Public Rights

Sale of private placement shares

Issuance of representative shares

Underwriters’ discount

Other offering expenses

Recognition of over-allotment liability

Accretion of ordinary share subject to redemption value

Balance as of June 30, 2025 (Unaudited)

number include up to 187,500, 187,500 and 38,750 ordinary shares subject to forfeiture if the over-allotment option is not exercised

in full or in part by the underwriters as of January 1, 2025, March 31, 2025 and June 30, 2025, respectively (see

accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

1 unchanged sentence

CONSOLIDATED STATEMENT OF CASH FLOWS

the three months ended March 31, 2026 and 2025 (Unaudited)

the six months ended June 30, 2026 and 2025 (Unaudited)

expressed in United States dollars (“US$”)

Three Months Ended

Six Months Ended

Cash Flows from Operating

Net income (loss)

Adjustments to reconcile net income (loss)

to net cash used in operating activities:

Adjustments to reconcile net income to net cash used in operating activities:

Income earned on marketable securities held

in Trust Account

Change in fair value of over-allotment liability

Changes in operating assets and liabilities:

4 unchanged sentences

Cash Flows from Investing

Purchase of investments held in Trust Account

Purchase of time deposit

2 unchanged sentences

Cash Flows from Financing

Repayment of promissory note to a related party

Proceeds from sale of public units through public offerings, net of underwriters’ discount

Proceeds from ordinary shares issued in private placement

Payment of offering costs

Net Cash Used in Financing

Net Cash Provided by Financing

Change in Cash

3 unchanged sentences

of Non-cash Investing and Financing Activities:

Issuance of representative shares

Accretion of ordinary

1 unchanged sentence

accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

WINTERGREEN ACQUISITION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Three Months ended March 31, 2026

1 — Organization and Business Operation

WINTERGREEN ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

For the Six Months ended June 30, 2026

Note 1 — Organization and Business Operation

Wintergreen Acquisition Corp.

(the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on April 29, 2024.

was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business

combination with one or more businesses (the “Business Combination”).

On November 6, 2025, the

Company formed a wholly-owned subsidiary, Wintergreen Acquisition Merger Subsidiary Corp., which is an exempted company incorporated under

the laws of the Cayman Islands, for the purpose of consummating a Business Combination.

As of March 31, 2026 and December 31,

2025, the Company had not commenced any operations.

For the period from April 29, 2024 (inception) through March 31, 2026, the Company’s

efforts have been limited to organizational activities as well as activities related to the Initial Public Offering (as defined below).

The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

On November 6, 2025, the Company formed a wholly-owned subsidiary, Wintergreen Acquisition Merger Subsidiary Corp., which is an exempted company incorporated under the laws of the Cayman Islands, for the purpose of consummating a Business Combination.

As of June 30, 2026 and December 31, 2025, the Company had not commenced any operations.

For the period from April 29, 2024 (inception) through June 30, 2026, the Company’s efforts have been limited to organizational activities as well as activities related to the Initial Public Offering (as defined below).

The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest.

will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and Private

Placement (as defined below).

The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and Private Placement (as defined below).

The Company has selected December 31 as its fiscal year end.

The Company’s founder and

sponsor is MACRO DREAM Holdings Limited, a British Virgin Island business company with limited liability (the “Sponsor”).

The Company’s founder and sponsor is MACRO DREAM Holdings Limited, a British Virgin Island business company with limited liability (the “Sponsor”).

The registration statement for the Company’s Initial Public Offering was declared effective on May 28, 2025.

Company consummated its Initial Public Offering of 5,000,000 units (the “Units” and, with respect to the Ordinary Shares included

in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $50,000,000 (the “Initial

Public Offering”, or “IPO”), and incurring offering costs of $1,308,056.

The Company granted the underwriter a 45-day

option to purchase up to an additional 750,000 Units at the Initial Public Offering price to cover over-allotments, if any.

2025, the over-allotment option was exercised in part, and 595,000 Units, at $10.00 per Unit were sold, generating gross proceeds of $5,950,000.

Meanwhile, 55,950 ordinary shares were issued to the underwriter at the closing of the IPO as representative shares (the “Representative

Shares”), and 55,950 representative shares will be issued as the deferred underwriting commission at the consummation of a Business

Simultaneously with the consummation

of the closing of the IPO, the Company consummated the private placement of an aggregate of 253,875

units (the “Placement Units”) to the Sponsor at a price of $10.00 per Unit, generating gross proceeds of $ 2,538,750

(the “Private Placement”, see Note 4).

On July 13, 2025, the remaining

unexercised over-allotment option to purchase up to 155,000

Units at $ 10.00

per Unit were expired and 38,750

Founder Shares were forfeited along with the expiry of the over-allotment option (see Note 5(i)).

The Company’s initial Business

Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets

held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding

the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into the initial Business Combination.

However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding

voting securities of the target or otherwise acquires an interest in the target sufficient for the post-transaction company not to be

required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

On May 30, 2025, the Company consummated its Initial Public Offering of 5,000,000 units (the “Units” and, with respect to the Ordinary Shares included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $50,000,000 (the “Initial Public Offering”, or “IPO”), and incurring offering costs of $1,308,056.

The Company granted the underwriter a 45-day option to purchase up to an additional 750,000 Units at the Initial Public Offering price to cover over-allotments, if any.

On May 29, 2025, the over-allotment option was exercised in part, and 595,000 Units, at $10.00 per Unit were sold, generating gross proceeds of $5,950,000.

Meanwhile, 55,950 ordinary shares were issued to the underwriter at the closing of the IPO as representative shares (the “Representative Shares”), and 55,950 representative shares will be issued as the deferred underwriting commission at the consummation of a Business Combination.

Simultaneously with the consummation of the closing of the IPO, the Company consummated the private placement of an aggregate of 253,875 units (the “Placement Units”) to the Sponsor at a price of $10.00 per Unit, generating gross proceeds of $ 2,538,750 (the “Private Placement”, see Note 4).

On July 13, 2025, the remaining unexercised over-allotment option to purchase up to 155,000 Units at $ 10.00 per Unit were expired and 38,750 Founder Shares were forfeited along with the expiry of the over-allotment option (see Note 5(i)).

The Company’s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into the initial Business Combination.

However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target sufficient for the post-transaction company not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

There is no assurance that the Company will be able to complete a Business Combination successfully.

Following the closing of the

IPO on May 30, 2025, an amount of $55,950,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and a portion

of the proceeds from the sale of the Placement Units was placed in a trust account (“Trust Account”) and invested in U.S.

government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, with a maturity of

185 days or less, or in money market funds meeting certain conditions of Rule 2a-7 of the Investment Company Act of 1940 which invest

only in direct U.S.

Following the closing of the IPO on May 30, 2025, an amount of $ 55,950,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and a portion of the proceeds from the sale of the Placement Units was placed in a trust account (“Trust Account”) and invested in U.S.

government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, with a maturity of 185 days or less, or in money market funds meeting certain conditions of Rule 2a-7 of the Investment Company Act of 1940 which invest only in direct U.S.

government treasury obligations, as determined by the Company.

The proceeds from this offering held in the trust account

will not be released from the trust account (1) to the Company, until the completion of the initial business combination, or (2) to public

shareholders, until the earliest of:

(a) the completion of the initial Business Combination, (b) the redemption of any ordinary shares

sold as part of the units in this offering (the “public shares”) properly submitted in connection with a shareholder vote

to amend the Company’s second amended and restated memorandum and articles of association (A) to modify the substance or timing

of the Company’s obligation to provide holders of the Company’s ordinary shares the right to have their shares redeemed in

connection with the Company’s initial business combination or to redeem 100% of the Company’s public shares if the Company

does not complete the initial business combination on August 30, 2026 or up to May 30, 2027 (an “Extension Period”)

or (B) with respect to any other provision relating to the rights of holders of the Company’s ordinary shares, and (c) the redemption

of the Company’s public shares if it has not consummated the business combination within 15 months from the closing of this offering

or during any Extension Period, subject to applicable law.

Public shareholders who redeem their ordinary shares in connection with a shareholder

vote described in clause (b) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion

of an initial business combination or liquidation if the Company has not consummated an initial business combination within 15 months

from the closing of this offering, with respect to such ordinary shares so redeemed.

The proceeds deposited in the trust account could

become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s

public shareholders.

The shareholders will be entitled

to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.025 per share, plus any pro

rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).

per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions

the Company will pay to the underwriter.

The ordinary shares subject to redemption will be recorded at a redemption value and classified

as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480

“Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company

has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder

approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company will have

only 15 months from the closing of the Initial Public Offering or during any Extension Period to complete the initial Business Combination

(the “Combination Period”).

If the Company is unable to complete the initial Business Combination within the Combination Period,

the Company will:

(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more

than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then

on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company

for working capital purposes or to pay the Company’s taxes (less up to $50,000 of interest to pay dissolution expenses), divided

by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders

(including the right to receive further liquidating distributions, if any);

and (iii) as promptly as reasonably possible following such

redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, dissolve and liquidate,

subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements

of other applicable law.

There will be no redemption rights or liquidating distributions with respect to the Company’s warrants,

which will expire worthless if the Company fails to complete the Business Combination within the 15 months from the closing of this offering

or during any Extension Period.

The Founder shares except as

described below, are identical to the ordinary shares included in the units being sold in this offering, and holders of Founder shares

have the same shareholder rights as public shareholders, except that (a) prior to the initial business combination, only holders of the

founder shares have the right to vote on the appointment of directors and holders of a majority of the founder shares may remove a member

of the board of directors for any reason;

(b) in a vote to continue the company in a jurisdiction outside of the Cayman Islands, holders

of founder shares will have ten votes for every founder share and holders of ordinary shares will have one vote for every ordinary share;

The proceeds from this offering held in the trust account will not be released from the trust account (1) to the Company, until the completion of the initial business combination, or (2) to public shareholders, until the earliest of:

(a) the completion of the initial Business Combination, (b) the redemption of any ordinary shares sold as part of the units in this offering (the “public shares”) properly submitted in connection with a shareholder vote to amend the Company’s second amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to provide holders of the Company’s ordinary shares the right to have their shares redeemed in connection with the Company’s initial business combination or to redeem 100% of the Company’s public shares if the Company does not complete the initial business combination on August 30, 2026 or up to May 30, 2027 (an “Extension Period”) or (B) with respect to any other provision relating to the rights of holders of the Company’s ordinary shares, and (c) the redemption of the Company’s public shares if it has not consummated the business combination within 15 months from the closing of this offering or during any Extension Period, subject to applicable law.

Public shareholders who redeem their ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial business combination or liquidation if the Company has not consummated an initial business combination within 15 months from the closing of this offering, with respect to such ordinary shares so redeemed.

The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.

The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.025 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).

The per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter.

The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $ 5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company will have only 15 months from the closing of the Initial Public Offering or during any Extension Period to complete the initial Business Combination (the “Combination Period”).

If the Company is unable to complete the initial Business Combination within the Combination Period, the Company will:

(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company for working capital purposes or to pay the Company’s taxes (less up to $ 50,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any);

and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete the Business Combination within the 15 months from the closing of this offering or during any Extension Period.

The Founder shares except as described below, are identical to the ordinary shares included in the units being sold in this offering, and holders of Founder shares have the same shareholder rights as public shareholders, except that (a) prior to the initial business combination, only holders of the founder shares have the right to vote on the appointment of directors and holders of a majority of the founder shares may remove a member of the board of directors for any reason;

(b) in a vote to continue the company in a jurisdiction outside of the Cayman Islands, holders of founder shares will have ten votes for every founder share and holders of ordinary shares will have one vote for every ordinary share;

(d) the Company’s initial

shareholder has entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with

respect to their Founder shares in connection with the completion of the Company’s initial Business Combination, (ii) waive their

redemption rights with respect to their Founder shares and public shares in connection with a stockholder vote to approve an amendment

to the Company’s second amended and restated memorandum and articles of association to (A) modify the substance or timing of the

Company’s obligation to provide for the redemption of the Company’s public shares in connection with an initial Business Combination

or to redeem 100% of the Company’s public shares if the Company has not consummated an initial Business Combination within 15 months

from the closing of this offering or during any Extension Period, and (B) with respect to any other provisions relating to shareholders’

rights, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder shares if the Company

fails to complete its initial Business Combination within 15 months from the closing of this offering or during any Extension Period,

(although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the

Company fails to complete its initial Business Combination within the prescribed time frame), and are entitled to registration rights.

If the Company submits its initial Business Combination to its public shareholders for a vote, its founder has agreed (and its permitted

transferees will agree) to vote their Founder shares, placement shares and any public shares purchased during or after this offering in

favor of its initial Business Combination.

The other members of the Company’s management team have entered into agreements similar

to the one entered into by the Company’s Sponsor with respect to any public shares acquired by them in or after this offering.

The Company will have until 15

months from the closing of the IPO (or up to 24 months from the closing of this offering if the Company extends the period of time to

consummate a Business Combination by up to nine additional months through nine one-month extensions of time, as further provided in the

Company’s amended and restated memorandum and articles of association) to consummate a Business Combination (the “Combination

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease

all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter,

redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including

interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes

as well as expenses relating to the administration of the trust account (less up to $50,000 of interest released to the Company to pay

taxes and potentially, dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely

extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any),

subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining

shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to our obligations under the Companies

Act to provide for claims of creditors and the requirements of other applicable law.

The underwriter has agreed to

waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business

Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that

will be available to fund the redemption of the Public Shares.

In the event of such distribution, it is possible that the per share value

of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

The Sponsor has agreed that it

will be liable to the Company if and to the extent any claims by a third party (other than our independent registered public accounting

firm) for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed

entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per public share and (ii) the

actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per

public share due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes.

This liability will not apply with respect to any claims by a third party or prospective target business who executed a waiver of any

and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters

of the IPO against certain liabilities, including liabilities under the Securities Act.

Moreover, in the event that an executed waiver

is deemed to be unenforceable against a third party, then the Company’s Sponsor will not be responsible to the extent of any liability

for such third party claims.

On November 17, 2025, the

Company entered into a Merger Agreement (the “Merger Agreement”) with Wintergreen Acquisition Merger Subsidiary Corp., a Cayman

Islands exempted company and wholly-owned subsidiary of the Company (the “Merger Sub”), and KIKA Technology INC., a Cayman

Islands exempted company (“KIKA”) (collectively with the Company and Merger Sub, the “Parties”, or each a “Party”).

Pursuant to the Merger Agreement, upon the terms and subject to the conditions therein and in accordance with the Cayman Islands Companies

Act (As Revised) (the “Cayman Companies Act”), the Parties intend to effect a business combination transaction whereby the

Merger Sub will merge with and into KIKA, with KIKA being the surviving entity and becoming a wholly owned subsidiary of the Company (the

“Proposed Business Combination”).

Simultaneously with the consummation of the Business Combination, the Company will change

its name to “KIKA Inc.” In connection with the Merger, the shareholders of KIKA (the “KIKA Shareholders”) will

receive ordinary shares of the Company (the “Consideration Shares”) in an amount equal to the Valuation of KIKA (as defined

in the Merger Agreement) divided by the Per Share Redemption Price (as defined in the Merger Agreement), rounded up to the nearest whole

The Consideration Shares will be allocated among the KIKA Shareholders in accordance with the Allocation Statement (as defined

in the Merger Agreement).

Company filed a Form 8-K with the SEC on November 17, 2025 to announce the Merger Agreement.

(d) the Company’s initial shareholder has entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder shares in connection with the completion of the Company’s initial Business Combination, (ii) waive their redemption rights with respect to their Founder shares and public shares in connection with a stockholder vote to approve an amendment to the Company’s second amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to provide for the redemption of the Company’s public shares in connection with an initial Business Combination or to redeem 100% of the Company’s public shares if the Company has not consummated an initial Business Combination within 15 months from the closing of this offering or during any Extension Period, and (B) with respect to any other provisions relating to shareholders’ rights, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder shares if the Company fails to complete its initial Business Combination within 15 months from the closing of this offering or during any Extension Period, (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within the prescribed time frame), and are entitled to registration rights.

If the Company submits its initial Business Combination to its public shareholders for a vote, its founder has agreed (and its permitted transferees will agree) to vote their Founder shares, placement shares and any public shares purchased during or after this offering in favor of its initial Business Combination.

The other members of the Company’s management team have entered into agreements similar to the one entered into by the Company’s Sponsor with respect to any public shares acquired by them in or after this offering.

The Company will have until 15 months from the closing of the IPO (or up to 24 months from the closing of this offering if the Company extends the period of time to consummate a Business Combination by up to nine additional months through nine one-month extensions of time, as further provided in the Company’s amended and restated memorandum and articles of association) to consummate a Business Combination (the “Combination Period”).

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes as well as expenses relating to the administration of the trust account (less up to $50,000 of interest released to the Company to pay taxes and potentially, dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to our obligations under the Companies Act to provide for claims of creditors and the requirements of other applicable law.

The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares.

In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than our independent registered public accounting firm) for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes.

This liability will not apply with respect to any claims by a third party or prospective target business who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act.

Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Company’s Sponsor will not be responsible to the extent of any liability for such third party claims.

On November 17, 2025, the Company entered into a Merger Agreement (the “Merger Agreement”) with Wintergreen Acquisition Merger Subsidiary Corp., a Cayman Islands exempted company and wholly-owned subsidiary of the Company (the “Merger Sub”), and KIKA Technology INC., a Cayman Islands exempted company (“KIKA”) (collectively with the Company and Merger Sub, the “Parties”, or each a “Party”) (the “KIKA Merger”).

Pursuant to the Merger Agreement, upon the terms and subject to the conditions therein and in accordance with the Cayman Islands Companies Act (As Revised) (the “Cayman Companies Act”), the Parties intend to effect a business combination transaction whereby the Merger Sub will merge with and into KIKA, with KIKA being the surviving entity and becoming a wholly owned subsidiary of the Company (the “Proposed Business Combination”).

Simultaneously with the consummation of the Business Combination, the Company will change its name to “KIKA Inc.” In connection with the Merger, the shareholders of KIKA (the “KIKA Shareholders”) will receive ordinary shares of the Company (the “Consideration Shares”) in an amount equal to the Valuation of KIKA (as defined in the Merger Agreement) divided by the Per Share Redemption Price (as defined in the Merger Agreement), rounded up to the nearest whole share.

The Consideration Shares will be allocated among the KIKA Shareholders in accordance with the Allocation Statement (as defined in the Merger Agreement).

The Company filed a Form 8-K with the SEC on November 17, 2025 to announce the Merger Agreement.

On April 16, 2026, the

Company filed a Registration Statement on Form S-4 with the SEC in connection with the KIKA Merger.

On July 2, 2026, the Company

filed Amendment No.

1 to the Form S-4.

On July 21, 2026, the Company filed Amendment No.

2 to the Form S-4.

On August 4, 2026, the

Company filed Amendment No.

3 to the Form S-4.

On August 12, 2026, the Company filed Amendment No.

4 to the Form S-4.

Going Concern Consideration

As of March 31, 2026, the Company

had $ 1,179,430

of cash in its operating bank account, working capital of $ 1,079,980

and net income of $ 371,705 for the three months ended March 31, 2026 .

In connection with the Company’s assessment of going

concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40 “Going Concern,” and

through the consummation of the IPO on May 30, 2025, the Company has sufficient funds for the working capital needs of the Company

until a minimum of one year from the date of issuance of these financial statements.

However, the Company has until May 30, 2027 to consummate

the Initial Business Combination.

If a business combination is not consummated by this date (unless extended in accordance with the Company’s

governing documents), there will be a mandatory liquidation and subsequent dissolution of the Company.

Management has determined that

the need to satisfy this mandatory liquidation, should a business combination not occur, and the potential subsequent dissolution, raises

substantial doubt about the Company’s ability to continue as a going concern.

The Company intends to complete

the Initial Business Combination before the mandatory liquidation date.

However, there can be no assurance that the Company will be able

to consummate any business combination by May 30, 2027.

No adjustments have been made

to the carrying amounts and classification of assets or liabilities should the Company be required to liquidate after such date.

2 — Significant Accounting Policies

of Presentation

The accompanying unaudited condensed

consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States

of America (“U.S.

As of June 30, 2026, the Company had $ 1,028,051 of cash in its operating bank account, working capital of $ 940,707 and net income of $ 741,521 for the six months ended June 30, 2026.

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40 “Going Concern,” and through the consummation of the IPO on May 30, 2025, the Company has sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial statements.

However, the Company has until May 30, 2027 to consummate the Initial Business Combination.

If a business combination is not consummated by this date (unless extended in accordance with the Company’s governing documents), there will be a mandatory liquidation and subsequent dissolution of the Company.

Management has determined that the need to satisfy this mandatory liquidation, should a business combination not occur, and the potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern.

The Company intends to complete the Initial Business Combination before the mandatory liquidation date.

However, there can be no assurance that the Company will be able to consummate any business combination by May 30, 2027.

No adjustments have been made to the carrying amounts and classification of assets or liabilities should the Company be required to liquidate after such date.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S.

GAAP”) and pursuant to the rules and regulations of the SEC.

Certain information or footnote disclosures

normally included in the financial statements prepared in accordance with U.S.

GAAP have been condensed or omitted, pursuant to the rules

and regulations of the SEC for interim financial reporting.

Accordingly, they do not include all of the information and disclosures necessary

for a complete presentation of financial position, results of operations or cash flows.

In the opinion of management, the accompanying

condensed consolidated financial statements include all adjustments which are considered necessary for a fair presentation of the financial

position, results of operations and cash flows for the periods presented.

The results of operations for the three months ended March 31,

2026 are not necessarily indicative of the operating results for the full year ending December 31, 2026 or any other future period.

The accompanying unaudited condensed

consolidated financial statements have been derived from the accounting records of the Company and should be read in conjunction with

the financial statements and notes as of December 31, 2025 and for the year ended December 31, 2025 thereto included in the

Company’s Form 10-K as filed with the SEC on February 27, 2026.

Certain information or footnote disclosures normally included in the financial statements prepared in accordance with U.S.

GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting.

Accordingly, they do not include all of the information and disclosures necessary for a complete presentation of financial position, results of operations or cash flows.

In the opinion of management, the accompanying condensed consolidated financial statements include all adjustments which are considered necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.

The results of operations for the six months ended June 30, 2026 are not necessarily indicative of the operating results for the full year ending December 31, 2026 or any other future period.

The accompanying unaudited condensed consolidated financial statements have been derived from the accounting records of the Company and should be read in conjunction with the financial statements and notes as of December 31, 2025 and for the year ended December 31, 2025 thereto included in the Company’s Form 10-K as filed with the SEC on February 27, 2026.

Principles of Consolidation

The unaudited condensed consolidated

financial statements include the financial statements of the Company and its wholly-owned subsidiary, Wintergreen Acquisition Merger Subsidiary

The unaudited condensed consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Wintergreen Acquisition Merger Subsidiary Corp.

for the purpose of consummating a Business Combination.

All transactions and balances among the Company and its subsidiary have

been eliminated upon consolidation.

Growth Company Status

The Company is an “emerging

growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as

modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions

from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but

not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404

of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,

and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden

parachute payments not previously approved.

Further, Section 102(b)(1)

of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until

private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class

of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.

Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging

growth companies but any such election to opt out is irrevocable.

The Company has elected not to opt out of such extended transition period

which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,

as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company

nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential

differences in accounting standards used.

The preparation of unaudited

condensed consolidated financial statements in conformity with U.S.

GAAP requires management to make estimates and assumptions that affect

the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed

consolidated financial statements and the reported amounts of income and expenses during the reporting period.

Making estimates requires management

to exercise significant judgment.

It is at least reasonably possible that the estimate of the effect of a condition, situation or set

of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in

formulating its estimate, could change in the near term due to one or more future confirming events.

Actual results could differ from

these estimates.

Significant estimates made by management in the unaudited condensed consolidated financial statements include, but are

not limited to, the fair value of public rights and the redemption value of redeemable shares.

Cash includes demand deposits

with banks that the company may deposit additional funds at any time and also effectively may withdraw funds at any time without prior

notice or penalty.

Securities Held in Trust Account

As of March 31, 2026, all of

the assets held in the Trust Account were held in U.S.

All transactions and balances among the Company and its subsidiary have been eliminated upon consolidation.

Emerging Growth Company Status

The Company is an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.

The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with U.S.

GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of income and expenses during the reporting period.

Making estimates requires management to exercise significant judgment.

It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events.

Actual results could differ from these estimates.

Significant estimates made by management in the unaudited condensed consolidated financial statements include, but are not limited to, the fair value of public rights and the redemption value of redeemable shares.

Cash includes demand deposits with banks that the company may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty.

Marketable Securities Held in Trust Account

As of June 30, 2026, all of the assets held in the Trust Account were held in U.S.

Treasury Securities Money Market Funds.

All of the Company’s investments

held in the Trust Account are classified as marketable securities.

Marketable securities are presented on the condensed consolidated balance

sheets at fair value at the end of each reporting period.

Gains and losses resulting from the change in fair value of investments held

in Trust Account are included in income earned on marketable securities held in Trust Account in the condensed consolidated statement

of operations and comprehensive income (loss).

The estimated fair values of marketable securities held in Trust Account are determined

using available market information.

As of March 31, 2026, the estimated fair value of marketable securities held in Trust Account was

$ 57,929,106 .

For the three months ended March 31, 2026, the Company recorded income earned on investments held in Trust Account of $ 503,470 .

Concentration

of Credit Risk

Financial instruments that potentially

subject the Company to concentration of credit risk consist of cash account in a financial institution and marketable securities held

in Trust Account, which, at times may exceed the Federal depository insurance coverage of $ 250,000 .

Also, the Company maintains certain

bank accounts in Hong Kong, where cash balances are protected under Deposit Protection Scheme in accordance with the Deposit Protection

Scheme Ordinance, with the maximum protection of up to HKD500,000 per depositor per Scheme member, including both principal and interest.

The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such

Costs Associated with the Initial Public Offering

Offering costs consisted of underwriting,

legal, accounting and other costs incurred through the IPO that were directly related to the IPO.

cost amounted to $1,308,056, consisting of $559,500 and $493,482 of underwriting commissions which were paid in cash and representative

shares (55,950 ordinary shares) at the closing date of the IPO, respectively and $255,074 of other offering costs.

The Company complies

with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”.

The Company allocates offering costs among public shares, public rights based on the relative fair values of public shares and public

Accordingly, $1,156,982 was allocated to public shares and charged to ordinary shares subject to possible redemption, and $151,075

was allocated to public rights and charged to shareholders’ equity.

Value of Financial Instruments

ASC Topic 820 “Fair Value

Measurements” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the

buyer and the seller at the measurement date.

In determining fair value, the valuation techniques consistent with the market approach,

income approach and cost approach shall be used to measure fair value.

ASC Topic 820 establishes a fair value hierarchy for inputs, which

represent the assumptions used by the buyer and seller in pricing the asset or liability.

These inputs are further defined as observable

and unobservable inputs.

Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market

data obtained from sources independent of the Company.

Unobservable inputs reflect the Company’s assumptions about the inputs that

the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

The fair value hierarchy is categorized

into three levels based on the inputs as follows:

Level 1 - Valuations based on unadjusted quoted prices in active markets for identical

assets or liabilities that the Company has the ability to access.

All of the Company’s investments held in the Trust Account are classified as marketable securities.

Marketable securities are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period.

Gains and losses resulting from the change in fair value of investments held in Trust Account are included in income earned on marketable securities held in Trust Account in the condensed consolidated statement of operations and comprehensive income (loss).

The estimated fair values of marketable securities held in Trust Account are determined using available market information.

As of June 30, 2026, the estimated fair value of marketable securities held in Trust Account was $ 58,438,195 .

For the three months ended June 30, 2026 and 2025, the Company recorded income earned on investments held in Trust Account of $ 509,089 and $ 203,822 , respectively.

For the six months ended June 30, 2026 and 2025, the Company recorded income earned on investments held in Trust Account of $ 1,012,559 and $ 203,822 , respectively.

Company reclassified its marketable securities held in the Trust Account from non-current to current assets as of June 30, 2026, as the

mandatory redemption date of May 30, 2027 is within one year from the condensed consolidated balance sheet date.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash account in a financial institution and marketable securities held in Trust Account, which, at times may exceed the Federal depository insurance coverage of $ 250,000 .

Also, the Company maintains certain bank accounts in Hong Kong, where cash balances are protected under Deposit Protection Scheme in accordance with the Deposit Protection Scheme Ordinance, with the maximum protection of up to HKD500,000 per depositor per Scheme member, including both principal and interest.

The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Offering Costs Associated with the Initial Public Offering

Offering costs consisted of underwriting, legal, accounting and other costs incurred through the IPO that were directly related to the IPO.

Offering cost amounted to $1,308,056, consisting of $559,500 and $493,482 of underwriting commissions which were paid in cash and representative shares (55,950 ordinary shares) at the closing date of the IPO, respectively and $255,074 of other offering costs.

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”.

The Company allocates offering costs among public shares, public rights based on the relative fair values of public shares and public rights.

Accordingly, $1,156,982 was allocated to public shares and charged to ordinary shares subject to possible redemption, and $151,075 was allocated to public rights and charged to shareholders’ equity.

Fair Value of Financial Instruments

ASC Topic 820 “Fair Value Measurements” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date.

In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value.

ASC Topic 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability.

These inputs are further defined as observable and unobservable inputs.

Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company.

Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

The fair value hierarchy is categorized into three levels based on the inputs as follows:

Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Valuation adjustments and block discounts are not being applied.

valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does

not entail a significant degree of judgment.

Level 2 - Valuations based on (i) quoted prices in active markets for similar assets

and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices

for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other

Level 3 - Valuations based on inputs that are unobservable and significant to the overall

fair value measurement.

The fair value of the Company’s

assets and liabilities, which qualify as financial instruments under ASC Topic 820 approximates the carrying amounts represented in the

accompanying condensed consolidated balance sheets, primarily due to their short-term nature.

The carrying amounts reported in the condensed

consolidated balance sheets for cash, accounts payable and accrued expenses and due to a related party, each qualify as financial instruments

and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected

realization and their current market rate of interest.

The following table presents

information about the Company’s assets that are measured at fair value on a recurring basis as of the presented periods, and indicates

the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

of assets and liabilities that are measured at fair value on a recurring basis

Marketable securities held in

Trust Account

Shares Subject to Possible Redemption

All of the 5,595,000

Ordinary Shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such Public Shares

in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination

and in connection with certain amendments to the Company’s amended and restated certificate of incorporation as disclosed in Note

The Company accounted for its

ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from

Equity” (ASC 480).

Ordinary shares subject to mandatory redemption (if any) were classified as a liability instrument and will be

measured at fair value.

Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either

within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s

control) were classified as temporary equity.

Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2 - Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820 approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature.

The carrying amounts reported in the condensed consolidated balance sheets for cash, accounts payable and accrued expenses and due to a related party, each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected realization and their current market rate of interest.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of the presented periods, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Schedule of assets and liabilities that are measured at fair value on a recurring basis

Marketable securities held in Trust Account

Ordinary Shares Subject to Possible Redemption

All of the 5,595,000 Ordinary Shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation as disclosed in Note 1.

The Company accounted for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480).

Ordinary shares subject to mandatory redemption (if any) were classified as a liability instrument and will be measured at fair value.

Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) were classified as temporary equity.

At all other times, ordinary shares were classified as stockholders’ equity.

In accordance

with ASC 480-10-S99, the Company classified the ordinary shares subject to redemption outside of permanent equity as the redemption provisions

are not solely within the control of the Company.

Given that the 5,595,000

ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying

value of ordinary shares, net of allocated offering cost, has been classified as temporary equity, and has been allocated to the proceeds

determined in accordance with ASC 470-20.

If it is probable that the equity instrument will become redeemable, the Company has the option

to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable

that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the

redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of

each reporting period.

The Company has elected the accretion method (i) to recognize the changes in redemption value as a charge against

retained earnings or, in the absence of retained earnings, as a charge against additional paid-in capital over an expected 15-month period,

which is the initial period that the Company has to complete a Business Combination.

For the three months ended March

31, 2026, the Company recorded accretion of ordinary share subject to redemption value of $ 2,033,969 .

Ordinary shares subject to possible

redemption reflected in the condensed consolidated balance sheet are recorded in the following table:

of ordinary shares subject to redemption

In accordance with ASC 480-10-S99, the Company classified the ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company.

Given that the 5,595,000 ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of ordinary shares, net of allocated offering cost, has been classified as temporary equity, and has been allocated to the proceeds determined in accordance with ASC 470-20.

If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period.

The Company has elected the accretion method (i) to recognize the changes in redemption value as a charge against retained earnings or, in the absence of retained earnings, as a charge against additional paid-in capital over an expected 15-month period, which is the initial period that the Company has to complete a Business Combination.

For the three months ended June 30, 2026 and 2025, the Company recorded accretion of ordinary share subject to redemption value of $ 2,056,593 and $ 517,668 , respectively.

For the six months ended June 30, 2026 and 2025, the Company recorded accretion of ordinary share subject to redemption value of $ 4,090,562 and $ 517,668 , respectively.

Ordinary shares subject to possible redemption reflected in the condensed consolidated balance sheet are recorded in the following table:

Schedule of ordinary shares subject to redemption

Gross proceeds

1 unchanged sentence

Offering costs allocated to redeemable shares

Accretion of carrying

value to redemption value

shares subject to possible redemption as of December 31, 2025

of carrying value to redemption value

shares subject to possible redemption as of March 31, 2026 (Unaudited)

Parties, which can be a corporation

or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise

significant influence over the other party in making financial and operational decisions.

Companies are also considered to be related

if they are subject to common control or common significant influence.

(Loss) Per Ordinary Share

The Company complies with accounting

and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”.

The unaudited condensed consolidated statements of

operations and comprehensive income include a presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable

share following the two-class method of income per share.

In order to determine the net income (loss) attributable to both the redeemable

shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares

and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid.

The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between

the redeemable and non-redeemable shares.

Any remeasurement of the accretion to redemption value of the shares subject to possible redemption

was considered to be dividends paid to the public shareholders.

Basic earnings per share (“EPS”)

is computed by dividing net income available to redeemable/non-redeemable shareholders by the weighted-average number of redeemable/non-redeemable

shares outstanding for the period.

Net income available to redeemable/non-redeemable shareholders represents net income of the Company

reduced by an allocation of earnings to participating securities.

Unvested share-based payment awards that contain non-forfeitable rights

to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS

pursuant to the two-class method.

Share-based payment awards that do not contain such rights are not deemed participating securities and

are included in diluted shares outstanding (if dilutive).

Diluted EPS is calculated under

the treasury stock method and the two-class method.

The calculation that results in the lowest diluted EPS amount for the redeemable/non-redeemable

shares is reported in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

stock method includes the dilutive effect of potential redeemable/non-redeemable shares including unvested stock-based awards.

redeemable shares associated with the over-allotment options are computed under the if-converted method.

For the three months ended March

31, 2026 and 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted

into common stock and then share in the earnings of the Company.

As a result, diluted income (loss) per share is the same as basic income

(loss) per share for the period presented.

Earnings (loss) per share presented

on the unaudited condensed consolidated statements of operations and comprehensive income (loss) is based on the following:

of Net income (loss) used in the calculation of basic and dilute EPS

Accretion of carrying value to redemption value

Ordinary shares subject to possible redemption as of December 31, 2025

Accretion of carrying value to redemption value

Ordinary shares subject to possible redemption as of June 30, 2026 (Unaudited)

Over-allotment Option

The over-allotment option granted to the underwriter was deemed to be a freestanding financial instrument indexed to the contingently redeemable shares and was accounted for as a liability pursuant to ASC Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”).

Upon the closing of the IPO on May 30, 2025, the over-allotment option was granted and represented the option to purchase up to 155,000 Units at $10.00 per Unit, which would expire on July 13, 2025.

The Company used Binomial option pricing model in the determination of the fair value of the over-allotment liability.

Key inputs used in the model are set forth as below:

Schedule of determination of the fair value of the over-allotment liability

Valuation date

Exercise price

Risk-free rate

July 13, 2025

June 30, 2025

July 13, 2025

On May 30, 2025 and June 30, 2025, the fair value of the over-allotment liability were $ 39,900 and $ 47,200 , respectively, and loss from change in fair value of over-allotment liability of $ 7,300 was recorded for the three and six months ended June 30, 2025.

Related Parties

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions.

Companies are also considered to be related if they are subject to common control or common significant influence.

Earnings (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”.

The unaudited condensed consolidated statements of operations and comprehensive income include a presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable share following the two-class method of income per share.

In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid.

The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares.

Any remeasurement of the accretion to redemption value of the shares subject to possible redemption was considered to be dividends paid to the public shareholders.

Basic earnings per share (“EPS”) is computed by dividing net income available to redeemable/non-redeemable shareholders by the weighted-average number of redeemable/non-redeemable shares outstanding for the period.

Net income available to redeemable/non-redeemable shareholders represents net income of the Company reduced by an allocation of earnings to participating securities.

Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the two-class method.

Share-based payment awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).

Diluted EPS is calculated under the treasury stock method and the two-class method.

The calculation that results in the lowest diluted EPS amount for the redeemable/non-redeemable shares is reported in the Company’s condensed consolidated statements of operations and comprehensive income.

The treasury stock method includes the dilutive effect of potential redeemable/non-redeemable shares including unvested stock-based awards.

Potential redeemable shares associated with the over-allotment options are computed under the if-converted method.

For the three and six months ended June 30, 2026, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company.

For the three and six months ended June 30, 2025, the effect of diluted securities was 12,163.

Net income (loss) used in the calculation of basic EPS is based on the following:

Schedule of Net income (loss) used in the calculation of basic and dilute EPS

Three Months Ended

Net income (loss)

Accretion of redeemable

ordinary shares to redemption value

loss including accretion of redeemable ordinary shares to redemption value

Earnings (loss) per share

presented on the unaudited condensed consolidated statement of operations and comprehensive income (loss) is based on the following:

Six Months Ended

Accretion of redeemable ordinary shares to redemption value

Net loss including accretion of redeemable ordinary shares to redemption value

Basic EPS presented on the unaudited condensed consolidated statement of operations and comprehensive income for the three months ended June 30, 2026 and 2025 is based on the following:

of unaudited condensed statement of operations and comprehensive income

For the Three Months Ended March 31,

For the Three Months Ended June 30,

Ordinary Share

7 unchanged sentences

ordinary shares to redemption value

Allocation of net income

Allocation of net

income (loss)

Denominators:

1 unchanged sentence

shares outstanding

Basic and diluted earnings

(loss) per share

The Company accounts for income

taxes under ASC 740 Income Taxes (“ASC 740”).

ASC 740 requires the recognition of deferred tax assets and liabilities for

both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future

tax benefit to be derived from tax loss and tax credit carry forwards.

ASC 740 additionally requires a valuation allowance to be established

when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting

for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement

process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued

interest and penalties related to unrecognized tax benefits as income tax expense.

There were no unrecognized tax benefits and no amounts

accrued for interest and penalties as of March 31, 2026 and December 31, 2025.

The Company is currently not aware of any issues under

review that could result in significant payments, accruals or material deviation from its position.

The Company determined that

the Cayman Islands is the Company’s only major tax jurisdiction.

The Company may be subject

to potential examination by taxing authorities in the areas of income taxes.

These potential examinations may include questioning the

timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws.

Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve

There is currently no taxation

imposed on income by the Government of the Cayman Islands for the three months ended March 31, 2026 and 2025.

Accounting Pronouncements

In November 2024, the

FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income —

Expense Disaggregation Disclosures(Subtopic 220-40):

Disaggregation of Income Statement Expenses (“ASU 2024-03”) which requires

detailed disclosures in the notes to financial statements disaggregating specific expense categories and certain other disclosures to

provide enhanced transparency into the nature and function of expenses.

The FASB further clarified the effective date in January 2025

with the issuance of ASU 2025-01, Income Statement — Reporting Comprehensive Income —

Expense Disaggregation Disclosures (Subtopic 220-40):

Basic earnings (loss)

Basic EPS presented on the unaudited condensed consolidated statement of operations and comprehensive income for the six months ended June 30, 2026 and 2025 is based on the following:

For the Six Months Ended June 30,

Ordinary Share

Non-Redeemable

Ordinary Share

Non-Redeemable

Ordinary Share

Allocation of net loss

Accretion of redeemable ordinary shares to redemption value

Allocation of net income (loss)

Denominators:

Weighted-average ordinary shares outstanding

Basic earnings (loss) per share

Net income (loss) used in the calculation of diluted EPS is based on the following:

of Net income (loss) used in the calculation of basic and dilute EPS

Three Months Ended

Six Months Ended

Accretion of redeemable ordinary shares to redemption value

accretion of ordinary share subject to redemption value of participating securities considered potentially dilutive

Net loss including accretion of redeemable ordinary shares to redemption value

Diluted EPS presented on the unaudited condensed consolidated statement of operations and comprehensive income for the three months ended June 30, 2026 and 2025 is based on the following:

Schedule of unaudited condensed statement of operations and comprehensive income

For the Three Months Ended June 30,

Ordinary Share

Non-Redeemable

Ordinary Share

Non-Redeemable

Ordinary Share

Allocation of net loss

Accretion of redeemable ordinary shares to redemption value

Allocation of net income (loss)

Denominators:

Weighted-average ordinary shares outstanding

Diluted earnings (loss) per share

Diluted EPS presented on the unaudited condensed consolidated statement of operations and comprehensive income for the six months ended June 30, 2026 and 2025 is based on the following:

For the Six Months Ended June 30,

Ordinary Share

Non-Redeemable

Ordinary Share

Non-Redeemable

Ordinary Share

Allocation of net loss

Accretion of redeemable ordinary shares to redemption value

Allocation of net income (loss)

Denominators:

Weighted-average ordinary shares outstanding

Diluted earnings (loss) per share

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”).

ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards.

ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense.

There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2026 and December 31, 2025.

The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company determined that the Cayman Islands is the Company’s only major tax jurisdiction.

The Company may be subject to potential examination by taxing authorities in the areas of income taxes.

These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws.

The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

There is currently no

taxation imposed on income by the Government of the Cayman Islands for the three and six months ended June 30, 2026 and

Recent Accounting Pronouncements

In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures(Subtopic 220-40):

Disaggregation of Income Statement Expenses (“ASU 2024-03”) which requires detailed disclosures in the notes to financial statements disaggregating specific expense categories and certain other disclosures to provide enhanced transparency into the nature and function of expenses.

The FASB further clarified the effective date in January 2025 with the issuance of ASU 2025-01, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40):

Clarifying the Effective Date ( “ ASU 2025-01 ” ).

ASU 2024-03 is effective for annual periods beginning after December 15,

2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted.

The requirements

should be applied on a prospective basis while retrospective application is permitted.

The Company does not expect to adopt this guidance

early and does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

On December 8, 2025, the

FASB issued ASU 2025-11 — Interim Reporting (“ASU 2025-11”) which is intended

to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies.

Under the amendments, an entity

is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP.

ASU 2025-11 also addresses the form

and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose

events since the end of the last annual reporting period that have a material impact on the entity.

ASU 2025-11 is effective for interim

reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted.

is currently evaluating the impact the adoption of ASU 2025-11 may have on its consolidated financial statements.

Management does not believe that

any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s

financial statements.

3 — Initial Public Offering

On May 30, 2025,

the Company consummated its

IPO of 5,000,000 Units, at $10.00 per Unit, generating gross proceeds of $50,000,000.

The Company granted the underwriter a 45-day option

to purchase up to an additional 750,000 Units at the IPO price to cover over-allotments.

On May 29, 2025, the over-allotment option

was exercised in part, and 595,000 Units, at $10.00 per Unit were sold, generating gross proceeds of $5,950,000 and deposited into the

Trust Account.

Each unit has an offering price

of $10.00 and consists of one ordinary share (“Public Share”) and one right (“Public Right”) to receive one-eighth

(1/8) of an ordinary share upon the consummation of the initial business combination.

The Company incurred offering

costs of approximately $ 1,308,056 ,

consisting of $ 559,500

and $ 493,482

of underwriting commissions which were paid in cash and Representative Shares (55,950 ordinary shares) at the closing date of the IPO,

respectively and $ 255,074

of other offering costs.

Meanwhile, pursuant the underwriting

agreement, 1.0% of the gross proceeds of the IPO, or $ 559,500 ,

will be paid in cash, and 55,950

representative shares will be issued, both of which as the deferred underwriting commission at the consummation of a Business Combination.

All of the 5,595,000

public shares sold as part of the Public Units in the IPO contain a redemption feature and the Company has classified related proceeds

in temporary equity as disclosed in Note 2.

4 — Private Placement

Simultaneously with the closing

of the IPO, the Sponsor purchased an aggregate of 253,875

Placement Units at a price of $10.00 per Placement Unit raising $ 2,538,750

in the aggregate.

The proceeds from the sale of

the Placement Units were added to the net proceeds from the IPO held in the Trust Account.

The Private Placement Units are identical to

the Public Units sold in this IPO, subject to limited exceptions.

The holder of the Private Placement Units will be entitled to registration

In addition, these Private Placement Units may not, subject to certain limited exceptions, be redeemable, transferred, assigned

or sold until the later of the completion of our initial business combination or 15 months following the closing of the IPO.

5 — Related Party Transactions

ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted.

The requirements should be applied on a prospective basis while retrospective application is permitted.

The Company does not expect to adopt this guidance early and does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

On December 8, 2025, the FASB issued ASU 2025-11 — Interim Reporting (“ASU 2025-11”) which is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies.

Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP.

ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity.

ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted.

The Company is currently evaluating the impact the adoption of ASU 2025-11 may have on its consolidated financial statements.

Management does not believe that any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Note 3 — Initial Public Offering

On May 30, 2025, the Company consummated its IPO of 5,000,000 Units, at $10.00 per Unit, generating gross proceeds of $50,000,000.

The Company granted the underwriter a 45-day option to purchase up to an additional 750,000 Units at the IPO price to cover over-allotments.

On May 29, 2025, the over-allotment option was exercised in part, and 595,000 Units, at $10.00 per Unit were sold, generating gross proceeds of $5,950,000 and deposited into the Trust Account.

Each unit has an offering price of $10.00 and consists of one ordinary share (“Public Share”) and one right (“Public Right”) to receive one-eighth (1/8) of an ordinary share upon the consummation of the initial business combination.

The Company incurred offering costs of approximately $ 1,308,056 , consisting of $ 559,500 and $ 493,482 of underwriting commissions which were paid in cash and Representative Shares (55,950 ordinary shares) at the closing date of the IPO, respectively and $ 255,074 of other offering costs.

Meanwhile, pursuant the underwriting agreement, 1.0% of the gross proceeds of the IPO, or $ 559,500 , will be paid in cash, and 55,950 representative shares will be issued, both of which as the deferred underwriting commission at the consummation of a Business Combination.

All of the 5,595,000 public shares sold as part of the Public Units in the IPO contain a redemption feature and the Company has classified related proceeds in temporary equity as disclosed in Note 2.

Note 4 — Private Placement

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 253,875 Placement Units at a price of $10.00 per Placement Unit raising $ 2,538,750 in the aggregate.

The proceeds from the sale of the Placement Units were added to the net proceeds from the IPO held in the Trust Account.

The Private Placement Units are identical to the Public Units sold in this IPO, subject to limited exceptions.

The holder of the Private Placement Units will be entitled to registration rights.

In addition, these Private Placement Units may not, subject to certain limited exceptions, be redeemable, transferred, assigned or sold until the later of the completion of our initial business combination or 15 months following the closing of the IPO.

Note 5 — Related Party Transactions

Nature of relationship with the related party:

The following is a list of the

related party, with which the Company has transactions:

Name of Related

MACRO DREAM Holdings

Founder and sponsor

of the Company

The following is a list of the related party, with which the Company has transactions:

Name of Related Parties

MACRO DREAM Holdings Limited

Founder and sponsor of the Company

Transactions with the related party:

(i) Founder Shares

On December 27, 2024, the

sponsor acquired 1,437,500

ordinary shares (“Founder shares”) for an aggregate purchase price of $ 25,000 .

On December 27, 2024, the sponsor acquired 1,437,500 ordinary shares (“Founder shares”) for an aggregate purchase price of $ 25,000 .

187,500 Founder Shares are subject to forfeiture to the extent that underwriter’s over-allotment option is not exercise in full or in part.

On May 30, 2025, the underwriters

exercised 595,000

over-allotment options out of total 750,000

with remaining unexercised of 155,000 .

On July 13, 2025, the remaining over-allotment options to purchase 155,000

Units were expired.

Accordingly, 38,750

Founder Shares were forfeited as the result.

As of March 31, 2026 and December 31,

2025, there were 1,398,750

and 1,398,750

Founder Shares issued and outstanding.

The sponsor has agreed not to

transfer, assign or sell their Founder Shares (excluding any units or shares comprising the units acquired in the offering) until the

earlier to occur of (a) 180 days after the completion of our initial business combination and (b) upon completion of our initial business

combination, (x) if the last reported sale price of our ordinary shares equals or exceeds $12.00 per unit (as adjusted for share subdivisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing

at least 150 days after our initial business combination or (y) the date on which we complete a liquidation, merger, share exchange, reorganization

or other similar transaction after our initial business combination that results in all of our shareholders having the right to exchange

their ordinary shares for cash, securities or other property.

Any permitted transferees would be subject to the same restrictions and

other agreements of our sponsor, directors and executive officers with respect to any Founder Shares.

On May 30, 2025, the underwriters exercised 595,000 over-allotment options out of total 750,000 with remaining unexercised of 155,000 .

On July 13, 2025, the remaining over-allotment options to purchase 155,000 Units were expired.

Accordingly, 38,750 Founder Shares were forfeited as the result.

As of June 30, 2026 and December 31, 2025, there were 1,398,750 and 1,398,750 Founder Shares issued and outstanding.

The sponsor has agreed not to transfer, assign or sell their Founder Shares (excluding any units or shares comprising the units acquired in the offering) until the earlier to occur of (a) 180 days after the completion of our initial business combination and (b) upon completion of our initial business combination, (x) if the last reported sale price of our ordinary shares equals or exceeds $12.00 per unit (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination or (y) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction after our initial business combination that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Any permitted transferees would be subject to the same restrictions and other agreements of our sponsor, directors and executive officers with respect to any Founder Shares.

(ii) Promissory Note — Related Party

On August 20, 2024, the

Company issued a promissory note to the sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $ 475,000

(the “Promissory Note”) to be used for a portion of the expenses for the IPO.

This loan is non-interest bearing,

unsecured and is due at the earlier of (1) March 31, 2025 or (2) the closing of the IPO.

The loan will be repaid upon the closing

of the IPO out of the offering proceeds not held in the Trust Account.

The Company has drawn down the full principal sum of the Promissory

Note for the period from April 29, 2024 (inception) through December 31, 2024.

On March 31, 2025, the sponsor

irrevocably waived the requirement that the principal balance of the Promissory Note shall be payable by the Company on March 31,2025.

And the principal balance of the Promissory Note shall remain payable by the Company on the date on which the Company consummates the

Shortly after completion of the

IPO, the promissory note was fully repaid.

On August 20, 2024, the Company issued a promissory note to the sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $ 475,000 (the “Promissory Note”) to be used for a portion of the expenses for the IPO.

This loan is non-interest bearing, unsecured and is due at the earlier of (1) March 31, 2025 or (2) the closing of the IPO.

The loan will be repaid upon the closing of the IPO out of the offering proceeds not held in the Trust Account.

The Company has drawn down the full principal sum of the Promissory Note for the period from April 29, 2024 (inception) through December 31, 2024.

On March 31, 2025, the sponsor irrevocably waived the requirement that the principal balance of the Promissory Note shall be payable by the Company on March 31,2025.

And the principal balance of the Promissory Note shall remain payable by the Company on the date on which the Company consummates the IPO.

Shortly after completion of the IPO, the promissory note was fully repaid.

(iii) Working Capital Loans

In addition, in order to

finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company’s officers and directors

may, but are not obligated to, loan the Company funds as may be required.

If the Company completes the initial Business Combination, it

intends to repay such loaned amount at closing.

In the event that the initial Business Combination does not close, the Company may use

a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would

be used for such repayment.

Up to $1,500,000 of such working capital loans (“Working Capital Loans”) made by the Sponsor,

the Company’s officers and directors, or the Company’s or their affiliates to the Company prior to or in connection with its

initial Business Combination may be convertible into units, at a price of $10.00 per unit at the option of the lender, upon consummation

of its initial Business Combination.

In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required.

If the Company completes the initial Business Combination, it intends to repay such loaned amount at closing.

In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment.

Up to $ 1,500,000 of such working capital loans (“Working Capital Loans”) made by the Sponsor, the Company’s officers and directors, or the Company’s or their affiliates to the Company prior to or in connection with its initial Business Combination may be convertible into units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination.

The units would be identical to the Placement Units.

For the three months ended

March 31, 2026 and 2025, the Company had no borrowings under the Working Capital Loans.

For the three and six months ended June 30, 2026 and 2025, the Company had no borrowings under the Working Capital Loans.

(iv) Administrative Services Arrangement

Commencing on the effective date

of the registration statement of the IPO, the Company has agreed to pay an affiliate of the Sponsor a total of $10,000 per month for office

space, utilities and secretarial and administrative support.

Upon completion of its initial Business Combination or its liquidation, the

Company will cease paying these monthly fees.

For the three months ended March

31, 2026, the Company has accrued $ 30,000 for the service provided by the Sponsor.

As of March 31, 2026 and December

31, 2025, the balance of amount due to a related party were $ 101,667

and $ 71,667 , respectively.

Commencing on the effective date of the registration statement of the IPO, the Company has agreed to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support.

Upon completion of its initial Business Combination or its liquidation, the Company will cease paying these monthly fees.

For the three months ended

June 30, 2026 and 2025, the Company has accrued $ 30,333 and $ 10,333 for the service provided by the Sponsor, respectively.

months ended June 30, 2026 and 2025, the Company has accrued $ 60,333 and $ 10,333 for the service provided by the Sponsor, respectively.

As of June 30, 2026 and December 31, 2025, the balance of amount due to a related party were $ 132,000 and $ 71,667 , respectively.

Balance with the related party:

of Balance with the related party

Amount due to the related

Schedule of Balance with the related party

Amount due to the related party:

Related party

1 unchanged sentence

Administrative support service fee

The amount due to the related party is non-interest

bearing and due on demand.

6 — Shareholder’s Equity

The amount due to the related party is non-interest bearing and due on demand.

Note 6 — Shareholder’s Equity

Ordinary Shares

The Company is authorized to

issue 500,000,000

ordinary shares with a par value of $ 0.0001

The Company is authorized to issue 500,000,000 ordinary shares with a par value of $ 0.0001 per share.

On April 29, 2024, the Company issued 1 ordinary share to Ogier Global Subscriber (Cayman) Limited (the “Subscriber”).

On May 14, 2024, the Subscriber transferred 1 ordinary share to the sponsor, meanwhile, the Company issued 9,999 ordinary shares

to the Sponsor for an aggregate purchase price of $1.

On August 20, 2024, the Sponsor made capital contribution of $ 25,000

to the Company in order to purchase Founder Shares.

On December 27, 2024, the Company issued 1,437,500

ordinary shares to the Sponsor including an aggregate of 187,500

shares that are subject to forfeiture to the extent that the underwriter’s over-allotment option is not exercised in full or in

part, so that the initial shareholder will own 20% of the Company’s issued and outstanding ordinary shares (excluding the Private

Placement Shares and Representative Shares (as described below) and assuming the initial shareholder does not purchase any shares in the

On May 14, 2024, the Subscriber transferred 1 ordinary share to the sponsor, meanwhile, the Company issued 9,999 ordinary shares to the Sponsor for an aggregate purchase price of $1.

On August 20, 2024, the Sponsor made capital contribution of $ 25,000 to the Company in order to purchase Founder Shares.

On December 27, 2024, the Company issued 1,437,500 ordinary shares to the Sponsor including an aggregate of 187,500 shares that are subject to forfeiture to the extent that the underwriter’s over-allotment option is not exercised in full or in part, so that the initial shareholder will own 20% of the Company’s issued and outstanding ordinary shares (excluding the Private Placement Shares and Representative Shares (as described below) and assuming the initial shareholder does not purchase any shares in the IPO).

Meanwhile, the Sponsor irrevocably surrendered to the Company for cancellation and for nil consideration of 10,000 ordinary shares.

On May 30, 2025, the Company

consummated its IPO of 5,000,000

units at $ 10.00

per Unit, with the exercise of the underwriter’s over-allotment option in part and 595,000

units were sold, generating gross proceeds of $ 55,950,000 .

Simultaneously with the consummation

of the closing of the IPO, the Company issued 253,875

ordinary shares to the Sponsor in the private placement and generating gross proceeds of $ 2,538,750 .

On May 30, 2025, the Company

issued 55,950

Representative Shares to the representative of the underwriters (and/or its designees) as part of the underwriting compensation.

The representative

shares have deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date

of the commencement of sales in this offering pursuant to FINRA Rule 5110I(1).

Pursuant to FINRA Rule 5110I(1), these securities

will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition

of the securities by any person for a period of 180 days immediately following the commencement of sales in this offering, nor may they

be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following May 30, 2025 except to any

underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates.

As of March 31, 2026 and December

31, 2025, as a result of closing of the IPO, the

exercise of the Representative’s over-allotment Option in part and the sales of Placement Units in the private placement, there

were 7,303,575 ordinary shares issued and outstanding, including 5,595,000 ordinary shares subject to possible redemption, which are classified

as temporary equity, and 1,708,575 ordinary shares.

1,708,575 ordinary shares issued and outstanding, consisted of 1,398,750 ordinary

shares of founder shares, 253,875 ordinary shares from private placement and 55,950 ordinary shares to the underwriter.

As of March 31, 2026 and December

31, 2025, there were 5,595,000 and 5,595,000 public rights included in the Public Units and 253,875 and 253,875 private rights include

in the Placement Units outstanding, respectively.

On May 30, 2025, the Company consummated its IPO of 5,000,000 units at $ 10.00 per Unit, with the exercise of the underwriter’s over-allotment option in part and 595,000 units were sold, generating gross proceeds of $ 55,950,000 .

Simultaneously with the consummation of the closing of the IPO, the Company issued 253,875 ordinary shares to the Sponsor in the private placement and generating gross proceeds of $ 2,538,750 .

On May 30, 2025, the Company issued 55,950 Representative Shares to the representative of the underwriters (and/or its designees) as part of the underwriting compensation.

The representative shares have deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in this offering pursuant to FINRA Rule 5110I(1).

Pursuant to FINRA Rule 5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the commencement of sales in this offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following May 30, 2025 except to any underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates.

As of June 30, 2026 and December 31, 2025, as a result of closing of the IPO, the exercise of the Representative’s over-allotment Option in part and the sales of Placement Units in the private placement, there were 7,303,575 ordinary shares issued and outstanding, including 5,595,000 ordinary shares subject to possible redemption, which are classified as temporary equity, and 1,708,575 ordinary shares.

1,708,575 ordinary shares issued and outstanding, consisted of 1,398,750 ordinary shares of founder shares, 253,875 ordinary shares from private placement and 55,950 ordinary shares to the underwriter.

As of June 30, 2026 and December 31, 2025, there were 5,595,000 and 5,595,000 public rights included in the Public Units and 253,875 and 253,875 private rights include in the Placement Units outstanding, respectively.

There was no right attached to the Representative Shares.

Except in cases where the

Company is not the surviving company in a Business Combination, each holder of a right will receive one-eighth (1/8) of an ordinary share

(the “Rights”) upon consummation of the initial Business Combination.

In the event the Company will not be the surviving company

upon completion of the Company’s initial Business Combination, each holder of a right will be required to affirmatively convert

his, her or its rights in order to receive the one-eighth (1/8) of a share of the Company underlying each right upon consummation of the

Business Combination unless otherwise waived in the course of the Business Combination.

No fractional shares will be issued upon exchange

No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon

consummation of a Business Combination.

Fractional shares will either be rounded down to the nearest whole share or otherwise addressed

in accordance with the applicable provisions of Cayman Law.

If the Company is unable to complete an initial Business Combination within

the required time period and the Company liquidates the funds held in the Trust Account, holders of Rights will not receive any of such

funds with respect to their Rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account

with respect to such Rights, and the Rights will expire worthless.

Further, there are no contractual penalties for failure to deliver

securities to the holders of the Rights upon consummation of an initial Business Combination.

Except in cases where the Company is not the surviving company in a Business Combination, each holder of a right will receive one-eighth (1/8) of an ordinary share (the “Rights”) upon consummation of the initial Business Combination.

In the event the Company will not be the surviving company upon completion of the Company’s initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-eighth (1/8) of a share of the Company underlying each right upon consummation of the Business Combination unless otherwise waived in the course of the Business Combination.

No fractional shares will be issued upon exchange of rights.

No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination.

Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman Law.

If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the Trust Account, holders of Rights will not receive any of such funds with respect to their Rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Rights, and the Rights will expire worthless.

Further, there are no contractual penalties for failure to deliver securities to the holders of the Rights upon consummation of an initial Business Combination.

Accordingly, the Rights may expire worthless.

7 — Commitments & Contingencies

Note 7 — Commitments & Contingencies

Registration Rights

The holders of the Founder Shares

and Private Placement Units (and their underlying securities) are entitled to registration rights pursuant to the registration rights

agreement signed on the effective date of the IPO, requiring the Company to register such securities for resale.

The holders of these

securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities.

the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the

completion of the initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415

under the Securities Act.

The holders of the Founder Shares and Private Placement Units (and their underlying securities) are entitled to registration rights pursuant to the registration rights agreement signed on the effective date of the IPO, requiring the Company to register such securities for resale.

The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities.

In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act.

The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

Company granted the underwriters a 45-day option from the effective date of the IPO to purchase up to an additional 750,000 units to cover

over-allotments at the IPO price.

On May 30, 2025, the over-allotment options were exercised in part, and 595,000 Units, at $10.00

per Unit were sold, generating gross proceeds of $5,595,000 and deposited into the Trust Account.

On July 13, 2025, the remaining over-allotment

options to purchase 155,000 Units were expired.

The underwriters were entitled

to an underwriting discount of 4.0% of the gross proceeds of the IPO, of which (i) 1% of the gross proceeds of the IPO, or $ 559,500 ,

were paid in cash at the closing of the IPO, (ii) 55,950

ordinary shares with fair value of $ 493,482

were paid at the closing of the IPO as Representative Shares (such representative shares shall be registered so as to circumvent reliance

on the Rule 144 exemption and shall only therein be subject to FINRA’s 180-day lock-up period rule), (iii) 1.0% of the gross

proceeds of the IPO, or 559,500, will be paid in cash, and 55,950

representative shares will be issued, both of which as the deferred underwriting commission at the consummation of a Business Combination.

8 — Segment Information

ASC Topic 280, “Segment

Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products,

services, geographic areas, and major customers.

Operating segments are defined as components of an enterprise that engage in business

activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is

regularly evaluated by the Company’s CODM, or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has

been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a

whole to make decisions about allocating resources and assessing financial performance.

Accordingly, management has determined that there

is only one reportable segment.

The CODM assesses performance

for the single segment and decides on resource allocation based on the net income or loss reported on the condensed consolidated statement

of operations and comprehensive income (loss).

The measure of segment assets is reported on the condensed consolidated balance sheets

as total assets.

When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews

several key metrics included in net income or loss and total assets, which include the following:

of net income loss

The Company granted the underwriters a 45-day option from the effective date of the IPO to purchase up to an additional 750,000 units to cover over-allotments at the IPO price.

On May 30, 2025, the over-allotment options were exercised in part, and 595,000 Units, at $10.00 per Unit were sold, generating gross proceeds of $5,595,000 and deposited into the Trust Account.

On July 13, 2025, the remaining over-allotment options to purchase 155,000 Units were expired.

The underwriters were entitled to an underwriting discount of 4.0% of the gross proceeds of the IPO, of which (i) 1% of the gross proceeds of the IPO, or $ 559,500 , were paid in cash at the closing of the IPO, (ii) 55,950 ordinary shares with fair value of $ 493,482 were paid at the closing of the IPO as Representative Shares (such representative shares shall be registered so as to circumvent reliance on the Rule 144 exemption and shall only therein be subject to FINRA’s 180-day lock-up period rule), (iii) 1.0% of the gross proceeds of the IPO, or 559,500, will be paid in cash, and 55,950 representative shares will be issued, both of which as the deferred underwriting commission at the consummation of a Business Combination.

Note 8 — Segment Information

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers.

Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s CODM, or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance.

Accordingly, management has determined that there is only one reportable segment.

The CODM assesses performance for the single segment and decides on resource allocation based on the net income or loss reported on the condensed consolidated statement of operations and comprehensive income.

The measure of segment assets is reported on the condensed consolidated balance sheets as total assets.

When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

Schedule of net income loss

Marketable securities held in Trust Account

of segment information

Schedule of segment information

Three Months Ended

Six Months Ended

Operating expenses

Income earned on marketable securities held

in Trust Account

The CODM reviews income earned

on marketable securities held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment

with the Trust Account funds while maintaining compliance with the Trust Agreement.

Operating expenses are reviewed

and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar

transaction within the Business Combination period.

The CODM also reviews operating expenses to manage, maintain and enforce all contractual

agreements to ensure costs are aligned with all agreements and budget.

Operating expenses, as reported on the condensed consolidated statements

of operations and comprehensive income (loss), are the significant segment expenses provided to the CODM on a regular basis.

Income earned on marketable securities held in Trust Account

The CODM reviews income earned on marketable securities held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

Operating expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period.

The CODM also reviews operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.

Operating expenses, as reported on the condensed consolidated statements of operations and comprehensive income, are the significant segment expenses provided to the CODM on a regular basis.

Assets Information

All of the Company’s operating

long-lived assets, including marketable securities held in Trust Account, were located in U.S.

as of March 31, 2026 and December 31,

9 — Subsequent Events

The Company evaluated subsequent

events and transactions that occurred after the balance sheet date through the date of these unaudited condensed consolidated financial

statements were issued.

The Company did not identify any subsequent events that would require adjustment or disclosure in the consolidated

financial statements except for those disclosed in other notes to these consolidated financial statements.

All of the Company’s operating long-lived assets, including marketable securities held in Trust Account, were located in U.S.

as of June 30, 2026 and December 31, 2025.

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date of these unaudited condensed consolidated financial statements were issued.

The Company did not identify any subsequent events that would require adjustment or disclosure in the consolidated financial statements except for those disclosed in other notes to these consolidated financial statements.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Financial Statements